Loading...

Caitlin Mulligan

Title(s)Assistant Clinical Professor, Neurosciences
SchoolHealth Sciences
Phone858-249-0856
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    UCLAMovement Disorders Fellowship
    UCLA Neurology Residency
    UC IrvineInternal Medicine Internship
    UC San DiegoMDMedical School

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Bursch B, Mulligan C, Keener AM, Aralis H, Lloyd J, Mogil C, Barrera W, Sinclair M, Lester P. Education Research: Evaluation of curriculum to teach resilience skills to neurology residents. Neurology. 2019 Mar 12; 92(11):538-541. PMID: 30858242.
      View in: PubMed
    2. Richter F, Gabby L, McDowell KA, Mulligan CK, De La Rosa K, Sioshansi PC, Mortazavi F, Cely I, Ackerson LC, Tsan L, Murphy NP, Maidment NT, Chesselet MF. Effects of decreased dopamine transporter levels on nigrostriatal neurons and paraquat/maneb toxicity in mice. Neurobiol Aging. 2017 03; 51:54-66. PMID: 28038352.
      View in: PubMed
    3. Richter F, Fleming SM, Watson M, Lemesre V, Pellegrino L, Ranes B, Zhu C, Mortazavi F, Mulligan CK, Sioshansi PC, Hean S, De La Rosa K, Khanna R, Flanagan J, Lockhart DJ, Wustman BA, Clark SW, Chesselet MF. A GCase chaperone improves motor function in a mouse model of synucleinopathy. Neurotherapeutics. 2014 Oct; 11(4):840-56. PMID: 25037721.
      View in: PubMed
    4. Richter F, Gao F, Medvedeva V, Lee P, Bove N, Fleming SM, Michaud M, Lemesre V, Patassini S, De La Rosa K, Mulligan CK, Sioshansi PC, Zhu C, Coppola G, Bordet T, Pruss RM, Chesselet MF. Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons. Neurobiol Dis. 2014 Sep; 69:263-75. PMID: 24844147.
      View in: PubMed
    5. Mulligan CK, Trauner DA. Incidence and behavioral correlates of epileptiform abnormalities in autism spectrum disorders. J Autism Dev Disord. 2014 Feb; 44(2):452-8. PMID: 23872941.
      View in: PubMed
    6. Fleming SM, Jordan MC, Mulligan CK, Masliah E, Holden JG, Millard RW, Chesselet MF, Roos KP. Impaired baroreflex function in mice overexpressing alpha-synuclein. Front Neurol. 2013; 4:103. PMID: 23888153.
      View in: PubMed
    7. Fleming SM, Mulligan CK, Richter F, Mortazavi F, Lemesre V, Frias C, Zhu C, Stewart A, Gozes I, Morimoto B, Chesselet MF. A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions. Mol Cell Neurosci. 2011 Mar; 46(3):597-606. PMID: 21193046.
      View in: PubMed
    8. Fleming SM, Tetreault NA, Mulligan CK, Hutson CB, Masliah E, Chesselet MF. Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. Eur J Neurosci. 2008 Jul; 28(2):247-56. PMID: 18702696.
      View in: PubMed